Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index

Background: Medication non-adherence in inflammatory bowel disease (IBD) has a negative impact on disease outcome. Different tools have been proposed to assess non-adherence. We aimed to compare a self-administered scale and a pharmacy refill index as a reliable measure of medication adherence and t...

Full description

Bibliographic Details
Main Authors: María-Luisa de-Castro, Luciano Sanromán, Alicia Martín, Montserrat Figueira, Noemí Martínez, Vicent Hernández, Víctor del-Campo, Juan-Ramón Pineda, Jesús Martínez-Cadilla, Santos Pereira, Ignacio Rodríguez-Prada
Format: Article
Language:English
Published: Aran Ediciones
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000800002&lng=en&tlng=en
_version_ 1818683907490447360
author María-Luisa de-Castro
Luciano Sanromán
Alicia Martín
Montserrat Figueira
Noemí Martínez
Vicent Hernández
Víctor del-Campo
Juan-Ramón Pineda
Jesús Martínez-Cadilla
Santos Pereira
Ignacio Rodríguez-Prada
author_facet María-Luisa de-Castro
Luciano Sanromán
Alicia Martín
Montserrat Figueira
Noemí Martínez
Vicent Hernández
Víctor del-Campo
Juan-Ramón Pineda
Jesús Martínez-Cadilla
Santos Pereira
Ignacio Rodríguez-Prada
author_sort María-Luisa de-Castro
collection DOAJ
description Background: Medication non-adherence in inflammatory bowel disease (IBD) has a negative impact on disease outcome. Different tools have been proposed to assess non-adherence. We aimed to compare a self-administered scale and a pharmacy refill index as a reliable measure of medication adherence and to determine what factors are related to adherence. Methods: Consecutive non-active IBD outpatients were asked to fill in the self-reported Morisky Medication Adherence Scale (MMAS-8) and the Beliefs about Medication Questionnaire (BMQ). Pharmacy refill data were reviewed from the previous three or six months and the medication possession ratio (MPR) was calculated. Non-adherence was defined as MMAS-8 scores < 6 or MPR < 0.8. Results: Two-hundred and three patients were enrolled (60% ulcerative colitis, 40% Crohn's disease); 51% were men, and the mean age was 46.3 (14) years. Seventy-four per cent of patients were on monotherapy and 26% on combination therapy; altogether, 65% received mesalazine, 46% thiopurines and 16% anti-tumor necrosis factor alfa. Non-adherence rate assessed by MPR was 37% and 22.4% by MMAS-8. Receiver operator curve analysis using a MMAS-8 cut-off of six gave an area under the curve of 0.6 (95% CI 0.5-0.7), p = 0.001. This score had an 85% sensitivity and 34% specificity to predict medication non-adherence, with negative and positive predictive values of 57% and 70% respectively. High scores in the BMQ potential for harm of medication were significantly associated with MPR non-adherence (p = 0.01). Conclusion: The accuracy of MMAS-8 to identify medication non-adherence in inactive IBD outpatients in our setting is poor due to a low specificity and a negative predictive value. Psychosocial factors such as beliefs about medication seem to be related to IBD non-adherence.
first_indexed 2024-12-17T10:42:12Z
format Article
id doaj.art-7530622f026c4b2b9d0c801044a61f3b
institution Directory Open Access Journal
issn 1130-0108
language English
last_indexed 2024-12-17T10:42:12Z
publisher Aran Ediciones
record_format Article
series Revista Espanola de Enfermedades Digestivas
spelling doaj.art-7530622f026c4b2b9d0c801044a61f3b2022-12-21T21:52:13ZengAran EdicionesRevista Espanola de Enfermedades Digestivas1130-0108109854255110.17235/reed.2017.5137/2017S1130-01082017000800002Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill indexMaría-Luisa de-Castro0Luciano Sanromán1Alicia Martín2Montserrat Figueira3Noemí Martínez4Vicent Hernández5Víctor del-Campo6Juan-Ramón Pineda7Jesús Martínez-Cadilla8Santos Pereira9Ignacio Rodríguez-Prada10Complexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoComplexo Hospitalario de VigoBackground: Medication non-adherence in inflammatory bowel disease (IBD) has a negative impact on disease outcome. Different tools have been proposed to assess non-adherence. We aimed to compare a self-administered scale and a pharmacy refill index as a reliable measure of medication adherence and to determine what factors are related to adherence. Methods: Consecutive non-active IBD outpatients were asked to fill in the self-reported Morisky Medication Adherence Scale (MMAS-8) and the Beliefs about Medication Questionnaire (BMQ). Pharmacy refill data were reviewed from the previous three or six months and the medication possession ratio (MPR) was calculated. Non-adherence was defined as MMAS-8 scores < 6 or MPR < 0.8. Results: Two-hundred and three patients were enrolled (60% ulcerative colitis, 40% Crohn's disease); 51% were men, and the mean age was 46.3 (14) years. Seventy-four per cent of patients were on monotherapy and 26% on combination therapy; altogether, 65% received mesalazine, 46% thiopurines and 16% anti-tumor necrosis factor alfa. Non-adherence rate assessed by MPR was 37% and 22.4% by MMAS-8. Receiver operator curve analysis using a MMAS-8 cut-off of six gave an area under the curve of 0.6 (95% CI 0.5-0.7), p = 0.001. This score had an 85% sensitivity and 34% specificity to predict medication non-adherence, with negative and positive predictive values of 57% and 70% respectively. High scores in the BMQ potential for harm of medication were significantly associated with MPR non-adherence (p = 0.01). Conclusion: The accuracy of MMAS-8 to identify medication non-adherence in inactive IBD outpatients in our setting is poor due to a low specificity and a negative predictive value. Psychosocial factors such as beliefs about medication seem to be related to IBD non-adherence.http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000800002&lng=en&tlng=enInflammatory bowel diseaseMedication adherencePatient complianceSurveys and questionnairesReproducibility of resultsPharmacy
spellingShingle María-Luisa de-Castro
Luciano Sanromán
Alicia Martín
Montserrat Figueira
Noemí Martínez
Vicent Hernández
Víctor del-Campo
Juan-Ramón Pineda
Jesús Martínez-Cadilla
Santos Pereira
Ignacio Rodríguez-Prada
Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index
Revista Espanola de Enfermedades Digestivas
Inflammatory bowel disease
Medication adherence
Patient compliance
Surveys and questionnaires
Reproducibility of results
Pharmacy
title Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index
title_full Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index
title_fullStr Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index
title_full_unstemmed Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index
title_short Assessing medication adherence in inflammatory bowel diseases: a comparison between a self-administered scale and a pharmacy refill index
title_sort assessing medication adherence in inflammatory bowel diseases a comparison between a self administered scale and a pharmacy refill index
topic Inflammatory bowel disease
Medication adherence
Patient compliance
Surveys and questionnaires
Reproducibility of results
Pharmacy
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017000800002&lng=en&tlng=en
work_keys_str_mv AT marialuisadecastro assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT lucianosanroman assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT aliciamartin assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT montserratfigueira assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT noemimartinez assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT vicenthernandez assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT victordelcampo assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT juanramonpineda assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT jesusmartinezcadilla assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT santospereira assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex
AT ignaciorodriguezprada assessingmedicationadherenceininflammatoryboweldiseasesacomparisonbetweenaselfadministeredscaleandapharmacyrefillindex